Treatment of large and giant colorectal polyps in the real world Stéphanie HUSSON, Guy VENTRE, Frédéric VAGNE, Jean François VIES, Marjorie MUSSO, Jean.

Slides:



Advertisements
Similar presentations
Tumors of Intestines.
Advertisements

A guaiac- based faecal occult blood colorectal cancer screening program involving general practitioners is feasible and cost-effective for mass population.
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Polyps – Where do they come from and what do you do with them?!
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Organized colorectal cancer screening program with FOBT: participation and diagnostic yield deteriorate with time Results – yield Aim To assess the short.
Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Colorectal Adenomas Santhat Nivatvongs MD Mayo Clinic Rochester Minnesota U. S.A.
Assessment of pathologic interpretation of colorectal polyps by general pathologists in community practice Bernard DENIS, Carol PETERS, Catherine CHAPELAIN,
The Adenoma/Carcinoma Sequence in the Colon
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
Management of Difficult Colonic Lesions
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Is upper endoscopy indicated in persons with a positive FOBT and a negative colonoscopy in a population-based colorectal cancer screening program ? Bernard.
Adverse effects of colorectal cancer screening with fecal occult blood test: a population-based organized program Results – serious adverse effects Adverse.
Malignant colonic polyp: endoscopic treatment updates
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
When Is A Colonoscopy Not a Colonoscopy
Joint Hospital Surgical Grand Round 19 June 2004.
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colonoscopy; Surveillance Indications
Colorectal cancer screening by primary care physicians: a prospective chart audit Bernard DENIS, Guillaume SCHON, Marcel RUETSCH, Jean Christian GRALL,
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
Colorectal carcinoma Dr.Mohammadzadeh.
© Copyright Annals of Internal Medicine, 2014 Ann Int Med. 160 (5): ITC5-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
Should colonoscopy be performed one year out from colorectal cancer resection? Alexandra Kent, Philip Thompson, Prof Alan Horgan, Mr Paul Hainsworth Newcastle.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Results and cost of a population-based biennial faecal occult blood colorectal cancer screening program Bernard DENIS, Philippe PERRIN, Jean François VIES,
Population Screening for Colorectal Cancer - update of evidences
Management of Serrated Polyps of Colorectum Eric YF Cheung Department of Surgery, NDH.
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
Colon polyps Peter Stanich, MD
Datum/Vortragsthema Local resection of Rectum tumors Peter M. Markus Elisabeth Hospital Essen Germany.
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Yield of colonoscopy for advanced neoplasia in a population-based setting Bernard DENIS, Jacques PICOT, Jean François VIES, Marjorie MUSSO, Paul François.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
First results of a pilot population-based faecal occult blood colorectal cancer screening program B. DENIS, P. PERRIN, J.F. EBELIN, P. WEBER, E. KALTENBACH,
Interval Colorectal Cancer 전임의 남지혁 Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Do we need colonoscopy in patients with gastric adenoma? The risk of colorectal adenoma in patients with gastric adenomas R3 Kim Jungwook Moon Hee Yang,
Clinical process indicators
BOWEL SCOPE SCREENING Dorset BCSP
27th Annual Winter CME Conference
Jasper Vleugels PhD-student AMC
Repeat Colonoscopy Recommendations
A Visual Tour of Effective Colonoscopy
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Volume 153, Issue 3, Pages (September 2017)
Volume 1, Issue 4, Pages (December 2016)
Polyps of the Colon and Rectum
A Visual Tour of Effective Colonoscopy
Volume 3, Issue 12, Pages (December 2018)
Volume 1, Issue 4, Pages (December 2016)
Volume 3, Issue 12, Pages (December 2018)
Risks of interval colorectal cancer in a FIT-based screening program
Colonoscopy in crc screening
Progastrin expression in colonic tissues and Kaplan–Meier survival curves. Progastrin expression in colonic tissues and Kaplan–Meier survival curves. A,
Presentation transcript:

Treatment of large and giant colorectal polyps in the real world Stéphanie HUSSON, Guy VENTRE, Frédéric VAGNE, Jean François VIES, Marjorie MUSSO, Jean Louis COLSON, Jacques PICOT, Jean Marc BOYAVAL, Daniel SONDAG, François KHACHOYAN, Isabelle GENDRE, Philippe PERRIN, Bernard DENIS Association pour le dépistage du cancer colorectal dans le Haut-Rhin (ADECA 68), Colmar, France

B. Denis - DDW 2007 – Washington DC background l large polyps ≥ 20 mm / giant ≥ 30 mm endoscopic resection effective and safe Walsh RM 1992, Dell’Abate P 2001, Brooker JC 2002, Seitz U 2003, Conio M 2004, Katsinelos P 2006 success rates ~ 1OO% Binmoeller KF 1996, Kanamori T 1996, Iishi H 2000, Stergiou N 2002, Doniec JM 2003, Bories E 2006, l how about the real world?

B. Denis - DDW 2007 – Washington DC aim to assess the success rate of endoscopic resection of large colorectal polyps in a population-based setting

B. Denis - DDW 2007 – Washington DC methods l population-based CRC screening program with guaiac based FOBT l 23 pilot areas l Haut-Rhin: residents aged y (Denis B et al. Gut 2007 in press)

B. Denis - DDW 2007 – Washington DC methods l retrospective study l all large polyps detected l CRC screening program in the Haut-Rhin l 3 year period (sept sept. 2006)

B. Denis - DDW 2007 – Washington DC results l 34 endoscopists (21 private practice) l 2968 colonoscopic procedures l 325 large polyps in 279 people (82 women) prevalence = 9.4%

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) size 20 – 29 mm215 (66.2) ≥ 30 mm 110 (33.8)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) shape pedunculated226 (69,5) sessile79 (24,3) flat11 (3,4)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) shape pedunculated226 (69,5) sessile79 (24,3) flat11 (3,4)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) location rectum48 (14,8) distal colon232 (71,4) proximal colon45 (13,8)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) location rectum48 (14,8) distal colon232 (71,4) proximal colon45 (13,8)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) type tubular119 (37,0) tubulo-villous174 (54,0) villous27 (8,4) serrated1 (0,3) hyperplastic1 (0,3)

B. Denis - DDW 2007 – Washington DC results – polyps characteristics n (%) dysplasia high-grade217 (66,8) T1 carcinoma31 (9,5)

B. Denis - DDW 2007 – Washington DC results – endoscopic resection l 247 polyps (76%) in 220 people l resection during u single session: 76.8% u 2nd procedure other expert endoscopist: 4.6% l En bloc resection: 67.2% l EMR: 8.6% l 2 bleeding / endoscopic treatment

B. Denis - DDW 2007 – Washington DC results – surgical resection l 78 polyps (24%) in 61 people l reasons u endoscopic resection failure: 44.0% u polyposis: 9.3% u malignant polyp: 46.7% l no complication

B. Denis - DDW 2007 – Washington DC endoscopic resection rate P< –29 mm >30 mmpedunc. sessile / flat

B. Denis - DDW 2007 – Washington DC endoscopic resection rate P=0.02 P<0.001 P<0.01

B. Denis - DDW 2007 – Washington DC endoscopic resection rate P<0.001

B. Denis - DDW 2007 – Washington DC conclusions (1) l largest series l 1 st in a population-based setting l in the real world u 1 / 5 patients with a benign large polyp is operated on u 2 / 5 with a benign giant polyp

B. Denis - DDW 2007 – Washington DC conclusions (2) l referral to surgery related to u sessile or flat shape u size, u proximal or rectal location, u malignancy and u lack of referral to an expert endoscopist l EMR performed by a minority (41.2%) l referral to an expert is rare (4.6%)

B. Denis - DDW 2007 – Washington DC future l need for u teaching (spreading) endoscopic techniques for the management of large polyps u promoting referral of difficult large polyps to expert endoscopists to avoid unnecessary surgery

B. Denis - DDW 2007 – Washington DC acknowledgements l all the 34 endoscopists practicing in the Haut-Rhin